Home › Funds › Prosight Management, LP › OKUR
Prosight Management, LP position in OKUR
ONKURE THERAPEUTICS INC · Health Care
Prosight Management, LP reported holding 1,325,570 shares of OKUR (ONKURE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$3.6M, representing 0.70% of its reported portfolio and ranking #22 among its reported holdings. Prosight Management, LP has disclosed OKUR holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Prosight Management, LP's OKUR position evolved
Prosight Management, LP first disclosed a stake in OKUR in Q4 2024 at 63,754 shares (US$548K). The position peaked in Q1 2026 at 2,154,381 shares, worth US$8.9M. Across 8 filings, Prosight Management, LP increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,325,570 shares valued at US$3.6M — an increase of 346,578 shares quarter over quarter.. Notable position changes include a 193% increase in Q1 2025 (shares fell 44% over the following quarter), a 205% increase in Q4 2025 (shares rose 43% over the following quarter), a 164% increase in Q1 2026 (shares rose 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 63.75K | $548.28K | New |
| Q1 2025 | 186.57K | $802.25K | Add |
| Q2 2025 | 159.69K | $381.66K | Reduce |
| Q3 2025 | 267.96K | $736.89K | Add |
| Q4 2025 | 816.91K | $2.37M | Add |
| Q1 2026 | 2.15M | $8.92M | Add |
| Q2 2026 | 978.99K | $4.46M | Reduce |
| Q3 2026 | 1.33M | $3.61M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About OKUR and 13F data
OKUR (ONKURE THERAPEUTICS INC) is a Health Care company. 70 other funds we track also report a position in OKUR — the largest reported positions include BVF INC/IL (US$14.8M), ACORN CAPITAL ADVISORS, LLC (US$12.9M), StepStone Group LP (US$12.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding OKUR
- BVF INC/IL 3.24M sh · $14.76M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 2.84M sh · $12.95M · Q2 2026
- StepStone Group LP 2.66M sh · $12.13M · Q2 2026
- ADAR1 Capital Management, LLC 2.24M sh · $10.21M · Q2 2026
- Trails Edge Capital Partners, LP 1.44M sh · $6.56M · Q2 2026
- Vivo Capital, LLC 1.93M sh · $5.25M · Q3 2026
- Sio Capital Management, LLC 1.08M sh · $4.92M · Q2 2026
- NEA Management Company, LLC 478.55K sh · $2.18M · Q2 2026
- Sofinnova Investments, Inc. 321.69K sh · $1.47M · Q2 2026
- Carlyle Group Inc. 269.89K sh · $735.46K · Q3 2026
- Rosalind Advisors, Inc. 150.00K sh · $684.00K · Q2 2026
- Stonepine Capital Management, LLC 162.82K sh · $443.68K · Q3 2026
More on Prosight Management, LP
FAQ
How long has Prosight Management, LP held OKUR?
Prosight Management, LP has disclosed OKUR holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Prosight Management, LP's current position in OKUR?
As of Q3 2026, Prosight Management, LP holds 1.33M shares of OKUR (ONKURE THERAPEUTICS INC), valued at $3.61M, representing 0.70% of its reported portfolio and ranking #22.
Has Prosight Management, LP been buying or selling OKUR?
In the latest 13F filing (Q3 2026), Prosight Management, LP increased its position in OKUR. The position peaked in Q1 2026 at 2.15M shares.
Which other funds hold OKUR?
Other major institutional holders of OKUR include BVF INC/IL, ACORN CAPITAL ADVISORS, LLC, StepStone Group LP, among 70 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.